Tug"" d^Ion 0F barked effect which is, however, influenced Uviaual factors and bv the strain of parasite.
The treatment of primary P. vivax or P. malaria infections with quinine in the usual doses (1 grm. daily) is followed by relapses in a proportion of individuals which may be as high as 50 per cent.
(5) The action of quinine on splenomegaly, when suitable treatment is applied in each attack, has proved to be of real efficacy in endemic regions, especially among children. It is but transient, however, if the community concerned is subject to a high proportion of relapses or is exposed to frequent reinfections.
(6) Quinine treatment with the usual doses does not affect the patient's general condition adversely and generally has no depressive or toxic effect, if the period of administration is limited to the strictly necessary number of days. In such a case, there is no good reason for thinking that this treatment hinders the processes of immunization, but ill effects may occur when treatment is unnecessarily protracted.
(b) Atebrin (1) Action on the trophozoites. Atebrin in daily doses of 0.30 grm. (for adults) has a slightly more rapid action on P. vivax trophozoites than quinine in the usual dose of 1 grm. The trophozoites disappear on an average after the third dose, and in some caseseven after the second. This parasiticidal action appears to continue for a longer period, in that the phase of latency of the disease (absence of clinical symptoms) is established more certainly and lasts somewhat longer after the end of treatment with atebrin than with quinine. On the trophozoites of P. malaria, the action of atebrin can be said to be of the same nature. On the trophozoites of P. falciparum, atebrin is equally in advance of quinine in certain cases; but the differences between the strains of parasite prevent the drawing of uniform conclusions. The trophozoites of P. falciparum disappear from the peripheral blood after the fourth dose of atebrin in 90 per cent of cases.
(2) The action oj atebrin on the gametocytes is of a similar nature to that of quinine; it has no effect, from the point of view of devitalization, on the gametocytes of P. falciparum. Bu-t the action on gametocytes already present in the blood is perhaps slightly more marked than that of quinine, particularly as regards the gametocytes of P. vivax and P. malaria.
(3) The action on the clinical symptoms of an acute attack is very marked, both in benign tertian and in malignant tertian. In some endemic regions, where
Ihere may possibly be special strains of P. falciparum, the therapeutic action of atebrin is even more energetic on malignant tertian than on benign tertian. [March, 1938 But, in other cases, the contrary seems to be true. This is why some practitioners and malariologists in tropical countries prefer to use quinine during the first days of the acute attack and to continue with atebrin thereafter. In benign tertian the fever nearly always falls after the first three therapeutic doses of atebrin? that is to say by the second attack. In malignant tertian the fever falls almost invariably by the third attack.
(4) The action of atebrin on relapses is slightly more effective than that of quinine, especially in the case of benign tertian and of certain strains of malignant tertian.
(5) The spleen rate in communities treated with atebrin seems to decrease somewhat more slowly than in communities treated with quinine, but the effects of the drug continue to be felt for a longer time during the observation period after the end of the treatment, the decrease in the percentage of There are thus two groups of patients to compare. The outstanding difference in the treatments in these two groups is that the new aniline derivatives were used almost as a routine in the one group and not at all in the other. 
